Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03790657 · ClinicalTrials.gov registry record · Phase 1
CONTROL Walking Study
A Phase 1 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 1
- Development phase
- 72
- Enrollment target
NCT03790657: Completed Phase 1 study, sponsored by VA Office of Research and Development.
NCT03790657 is a Phase 1 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03790657, a Phase 1 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 72 participants
- Enrollment target
Study Summary
Older adults often experience substantial deficits in walking ability, especially for walking tasks that are more complex such as obstacle crossing. This is due in part to changes in the brain that make performance of physical and cognitive tasks more difficult. Rehabilitation can help to improve walking ability, but effective rehabilitation is time consuming and expensive. New approaches are needed to improve the efficiency of rehabilitation so that gains in walking ability are widely attainable. A promising strategy is to focus on enhancing motor learning, which is defined as improved ability to perform a motor task due to practice or experience. The investigators will investigate the use of non-invasive brain stimulation to increase motor learning and retention of the newly learned walking skills. The investigators will also use neuroimaging to assess brain characteristics that explain how motor learning works. The knowledge gained from this study is expected to contribute to better understanding of mechanistic targets and intervention approaches to improve rehabilitation of walking.
Interventions
- BEHAVIORAL practice of a complex walking task
- DEVICE Active transcranial direct current stimulation (Active tDCS)
- DEVICE Sham transcranial direct current stimulation (Sham tDCS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2024-08-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03790657
The ClinicalTrials.gov registry entry for NCT03790657 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which practice of a complex walking task is the first listed.
NCT03790657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03790657 about?
NCT03790657 is a clinical study titled "CONTROL Walking Study". Older adults often experience substantial deficits in walking ability, especially for walking tasks that are more complex such as obstacle crossing. This is due in part to changes in the brain that make performance of physical and cognitive tasks more difficult. Rehabilitation can help to improve wa...
What is the current status of trial NCT03790657?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 72 participants. The study started on 2019-08-01. Estimated completion is 2024-08-01.
What interventions are being tested in trial NCT03790657?
The interventions under investigation include: practice of a complex walking task (BEHAVIORAL), Active transcranial direct current stimulation (Active tDCS) (DEVICE), Sham transcranial direct current stimulation (Sham tDCS) (DEVICE).
Who is sponsoring clinical trial NCT03790657?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.